-

    updated on August 9, 2024

WS.I - Nanomedicine

updated on September 6, 2024

 ROOM 11

WS.I

NANOMEDICINE:
FROM RESEARCH TO CLINIC APPLICATION
 

September 12

Co-organized with:
Unimore FONDAZIONE DON GNOCCHI VOLTO

WORKSHOP COMMITTEE: 

Giovanni TOSI, Full Professor, University of Modena & Reggio Emilia, Secretary of European Technology Platform for Nanomedicine
Marzia BEDONI, Head of Nanomedicine and Biophotonics Unit in Don Gnocchi Foundation

The session will deal with precision approaches for diagnosis and therapy, as well as gene therapy and drug-based RNA/DNA technologies with applications in cancer, neurological diseases, cardiovascular, rare and genetic diseases.
 
September 12
09:00 - 10:30
Nanomedicine: Successful Stories
WS.I.1 - TT.V.J
Chairs: Giovanni TOSI, University of Modena and Reggio Emilia & Marzia BEDONI, Don Gnocchi Foundation
Research in the field of nanomedicine is continuously advancing; however, to bring real solutions into clinical practice, it is essential to align research closely with regulatory considerations, technology transfer, and ultimately, the marketing of products. In this session, international experts will explore some of the most recent and successful developments in nanomedicine research, emphasizing the significant impact that nano-products can have on clinical settings 
WS.I.1.1
TT.V.J.1
Alexandre CECCALDI
ETPN
Current and Emerging Nanomedicine Innovations: Success Stories from the European Frontlines
!NEUTRO PPT eceded
WS.I.1.2
TT.V.J.2
Lorena DIEGUEZ
International Iberian Nanotechnology Laboratory (INL)
Nano-medical devices for liquid biopsy: our tech transfer journey
!DONNA PPT eceded
WS.I.1.3
TT.V.J.3
Francesca RE
University of Milano Bicocca
Patient-derived Glioblastoma Stem Cell Secretome Modulates Blood-Brain Barrier Permeability
via RAGE-Dependent Signaling Pathway
!NEUTRO PPT eceded
 
11:30 - 13:00
Nanomedicine: Progresses in Nanomedicine
WS.I.2 - TT.VI.K
Chairs: Giovanni TOSI, University of Modena and Reggio Emilia & Marzia BEDONI, Don Gnocchi Foundation
In this session, recent progress in nanomedicine academic research will be presented. From the initial conceptualization of nanomedicine design to the final efficacy tests, speakers will discuss the crucial step of deeply analyzing the interaction between the nano-product and the biological environment. During this session, experts will highlight the tight connection between the biological response to nano-products and their design, emphasizing how this relationship influences the effectiveness and safety of nanomedicine applications. 
WS.I.2.1
TT.VI.K.1
Fabiana QUAGLIA
University of Naples
Italian National Center for Gene Therapy
!NEUTRO PPT eceded
WS.I.2.2
TT.VI.K.2
Valentina CAUDA
Polytechnic University of Turin
Rational Design of nanoparticles mimicking extracellular vesicles
!NEUTRO PPT eceded
WS.I.2.3
TT.VI.K.3
Francesca RODÀ
University of Modena and Reggio Emilia & Don Gnocchi Foundation
mRNA-LNP Ex Vivo Interactions with Human Whole Blood
!NEUTRO PPT eceded
 
14:00 - 15:30
Nanomedicine: Innovation
WS.I.3 - TT.VII.K
Chairs:  Giovanni TOSI, University of Modena and Reggio Emilia & Marzia BEDONI, Fondazione Don Gnocchi
In this session, we will explore groundbreaking advancements in technology that are revolutionizing the healthcare sector. This session will cover fundamental topics that are crucial for the progression of nanomedicine, showcasing the latest developments and key applications in treating diseases that have been notoriously difficult to manage. Speakers and experts delve into how nanotechnology is paving the way for innovative therapeutic approaches, offering new hope for conditions that have long challenged traditional medicine, shaping the future of healthcare and the role of nanomedicine in transforming patient outcomes. 
WS.I.3.1 TT.VII.K.1 Sabrina CUOGHI
University of Modena and Reggio Emilia
Microfluidic and enzyme replacement therapy: PLGA Nanoparticles towards the development of new versatile therapeutic solutions
!NEUTRO PPT eceded
WS.I.3.2 TT.VII.K.2 Carlotta MARIANECCI
Sapienza University of Rome
Surfactant based nanobubbles: a combined strategy to enhance brain delivery
!NEUTRO PPT eceded
WS.I.3.3 TT.VII.K.3 Luigi CALZOLAI
ISPRA, JRC European Community
Advanced Characterization of Lipid-RNA therapeutics
!NEUTRO PPT eceded
 

 

 
freccia SX f54 Back to Overview Go to Plan 12 September freccia DX f54
 

 

INFO & CONTACTS

Dr. Federica SCROFANI

Tel. +39 06 49766676
Mob. +39 339 7714107
email: This email address is being protected from spambots. You need JavaScript enabled to view it.